Adult pancreatic neuroblastoma, an unusual site and fatal outcome.

Pathol Oncol Res

Department of Pathology, Faculty of Medicine, Menofiya University, Shebein Elkom, Egypt.

Published: April 2012

In this report, we describe a classic case of stroma rich neuroblastoma, nodular type in a 22 year old female presented with a pancreatic mass. This rare and unusual presentation elicits several differential diagnostic categories including solid pseudopapillary tumor, pancreatic endocrine tumor, pancreatoblastoma and PNET. In this report, we tried to differentiate between them depending on the histopathological features and using panel of epithelial and neuroendocrine markers. Although of the rarity of pancreatic neuroblastoma as a primary site of origin, however it should be considered in the differential diagnosis of pancreatic masses in children and young adult. Neuropil and ganglionic differentiation are helpful features to recognize neuroblastoma and differentiate them from other small blue cell tumors. The fatal outcome of adult neuroblastoma confirming the independence of age as a prognostic factor in this neoplasm regardless of stage and histology.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12253-011-9434-3DOI Listing

Publication Analysis

Top Keywords

pancreatic neuroblastoma
8
fatal outcome
8
neuroblastoma
5
adult pancreatic
4
neuroblastoma unusual
4
unusual site
4
site fatal
4
outcome report
4
report describe
4
describe classic
4

Similar Publications

Background And Aims: Image Defined Risk Factors (IDRFs) assess surgical risk in neuroblastoma (NB) and guide neoadjuvant therapy. Despite chemotherapy IDRFs may persist in 70 % of cases. Several studies have suggested that not all IDRFs hold equal significance and that the presence of an IDRF does not inherently signify unresectability.

View Article and Find Full Text PDF

Isoorientin: Unveiling the hidden flavonoid's promise in combating cancer development and progression - A comprehensive review.

Life Sci

January 2025

Department of Biochemistry and Pharmacology, School of Medicine, Universidade de Marília (UNIMAR), Marília 17525-902, São Paulo, Brazil; Postgraduate Program in Structural and Functional Interactions in Rehabilitation, School of Medicine, Universidade de Marília (UNIMAR), Marília 17525-902, São Paulo, Brazil; Department of Biochemistry and Nutrition, School of Food and Technology of Marília (FATEC), Marília 17500-000, São Paulo, Brazil; UNIMAR Charity Hospital, Universidade de Marília (UNIMAR), Marília 17525-902, São Paulo, Brazil.

Cancer remains one of the leading causes of mortality worldwide, characterized by uncontrolled cell growth and the ability of tumors to invade surrounding tissues and spread to distant organs. Despite significant advancements in early detection, diagnosis, and treatment, many cancers still present substantial challenges due to their heterogeneity, resistance to conventional therapies, and severe side effects of existing treatments. Consequently, there is an ongoing need for novel therapeutic agents to selectively target cancer cells, enhance the efficacy of current treatments, and minimize adverse effects.

View Article and Find Full Text PDF

Neuroblastoma is an aggressive malignancy commonly found in children, with adult patients being quite rare. Pancreatic neuroblastoma, even among adult cases, is especially rare. We present a case of a 26-year-old woman presented with mild abdominal pain and a palpable mass diagnosed as neuroblastoma affecting the pancreas.

View Article and Find Full Text PDF
Article Synopsis
  • c-MYC is a crucial factor in the development of high-risk neuroblastoma, and the lack of mouse models has limited research on its mechanisms and therapy development.
  • Inducing c-MYC through different promoters showed varied tumor types: using a tyrosine hydroxylase promoter led to pancreatic tumors, while a dopamine β-hydroxylase promoter resulted in neuroblastoma.
  • The neuroblastoma tumors in mice exhibited similar characteristics to human neuroblastoma and responded to existing treatments, highlighting the importance of these models for testing new therapies.
View Article and Find Full Text PDF
Article Synopsis
  • * A new liquid chromatography-mass spectrometry (LC-MS) method was developed to effectively profile gangliosides, optimizing both the extraction and analysis processes for better accuracy and recovery.
  • * This study found that the ganglioside profiles vary significantly across different cancer cell lines, indicating the potential of the method for identifying specific lipid markers related to cancer types.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!